23.68
5.81%
1.30
After Hours:
23.70
0.02
+0.08%
Stevanato Group Spa stock is traded at $23.68, with a volume of 403.99K.
It is up +5.81% in the last 24 hours and up +17.99% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$22.38
Open:
$22.44
24h Volume:
403.99K
Relative Volume:
0.82
Market Cap:
$6.46B
Revenue:
$1.19B
Net Income/Loss:
$124.38M
P/E Ratio:
50.79
EPS:
0.4662
Net Cash Flow:
$-678.26M
1W Performance:
+9.58%
1M Performance:
+17.99%
6M Performance:
+31.70%
1Y Performance:
-6.55%
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Compare STVN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
23.68 | 6.46B | 1.19B | 124.38M | -678.26M | 0.4662 |
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-13-24 | Initiated | Wolfe Research | Outperform |
Dec-03-24 | Resumed | Morgan Stanley | Equal-Weight |
Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
Sep-26-23 | Initiated | Stephens | Overweight |
Sep-19-23 | Initiated | CJS Securities | Market Outperform |
Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Aug-10-21 | Initiated | BofA Securities | Buy |
Aug-10-21 | Initiated | Citigroup | Buy |
Aug-10-21 | Initiated | Jefferies | Buy |
Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
Aug-10-21 | Initiated | Morgan Stanley | Overweight |
Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
Stevanato Group (NYSE:STVN) Trading Up 4.9%What's Next? - MarketBeat
State Street Corp Decreases Holdings in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
S&P 500 Futures Drop in Premarket Trading; Sportradar Group, Cytokinetics Lead - Barron's
Stifel Financial Corp Cuts Stock Holdings in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Stevanato Group S.p.A. (NYSE:STVN) Position Lessened by Stifel Financial Corp - MarketBeat
S&P 500 Futures Steady in Premarket Trading; Stevanato Group, Clearway Energy Lead - Barron's
How the (STVN) price action is used to our Advantage - Stock Traders Daily
Stevanato Group (NYSE:STVN) Research Coverage Started at Wolfe Research - Defense World
Fill Finish Manufacturing Market Growth in Future Scope - openPR
Stevanato Group (NYSE:STVN) Price Target Raised to $26.00 - Defense World
Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Wolfe Research Initiates Coverage of Stevanato Group S.p.A. (STVN) with Outperform Recommendation - MSN
Stevanato Group (NYSE:STVN) Trading Up 4.9% Following Analyst Upgrade - Defense World
Wolfe Research sets price target on Stevanato shares, sees growth By Investing.com - Investing.com Nigeria
Wolfe Research sets price target on Stevanato shares, sees growth - Investing.com
Stevanato Group (NYSE:STVN) Trading Up 1.7%Time to Buy? - MarketBeat
Stevanato Group S.p.A. (NYSE:STVN) Shares Acquired by Wellington Management Group LLP - MarketBeat
Stevanato Group (NYSE:STVN) Stock Price Up 1.5%Here's What Happened - MarketBeat
Stevanato Group S.p.A. (NYSE:STVN) Not Lagging Market On Growth Or Pricing - Simply Wall St
Where are the Opportunities in (STVN) - Stock Traders Daily
Stevanato Group (NYSE:STVN) Stock Price Up 0.5%Should You Buy? - MarketBeat
S&P 500 Futures Climb in Premarket Trading; Pure Storage, Okta Lead - Barron's
Morgan Stanley sets price target, equalweight for Stevanato Group shares - Investing.com
Morgan Stanley sets price target, equalweight for Stevanato Group shares By Investing.com - Investing.com Nigeria
Stevanato Group (NYSE:STVN) Trading Down 2.1%What's Next? - MarketBeat
Stevanato Group SpA (STVN) Trading Down 3.32% on Dec 2 - GuruFocus.com
Stevanato Group S.p.A. (NYSE:STVN) Sees Large Decrease in Short Interest - MarketBeat
Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by Fred Alger Management LLC - MarketBeat
Stevanato Group (NYSE:STVN) Trading Up 0.6%What's Next? - MarketBeat
S&P 500 Futures Rise in Premarket Trading; Stevanato Group, XP Lag - Barron's
(STVN) Long Term Investment Analysis - Stock Traders Daily
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On - GuruFocus.com
Stevanato Group (NYSE:STVN) vs. Todos Medical (OTCMKTS:TOMDF) Financial Contrast - Defense World
Stevanato Group (NYSE:STVN) Stock Price Down 0.4%Here's Why - MarketBeat
Stevanato Group SpA (STVN) Trading Down 6.47% on Nov 19 - GuruFocus.com
Objective long/short (STVN) Report - Stock Traders Daily
Frank Sands Reduces Stake in Stevanato Group SpA - GuruFocus.com
Stevanato S p A : 2R Vials and Deep Cold StorageDetermining Mechanical & CCI performances - Marketscreener.com
Significant Acquisition by T. Rowe Price Investment Management i - GuruFocus.com
Pharmaceutical Visual Inspection Systems Market Report: - openPR
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha
Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think - Simply Wall St
Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders - Yahoo Finance
Stevanato Group to Present at Upcoming Investor Conferences - The Bakersfield Californian
Auto-injectors: syringe-based and cartridge-based autoinjectors - Stevanato Group
Wellington Management Group LLP Bolsters Position in Stevanato G - GuruFocus.com
Stevanato Group S.p.A. Just Missed EarningsBut Analysts Have Updated Their Models - Simply Wall St
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):